143 related articles for article (PubMed ID: 2904683)
1. Immunology of infection with the human immunodeficiency virus.
Seligmann M
Recenti Prog Med; 1988; 79(7-8):330-7. PubMed ID: 2904683
[No Abstract] [Full Text] [Related]
2. Immunology in AIDS in 1990.
Sela M
AIDS; 1990; 4 Suppl 1():S9-14. PubMed ID: 1983804
[No Abstract] [Full Text] [Related]
3. HIV/AIDS vaccines: 2007.
Robinson HL
Clin Pharmacol Ther; 2007 Dec; 82(6):686-93. PubMed ID: 17971817
[TBL] [Abstract][Full Text] [Related]
4. Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development.
Betts MR; Gray CM; Cox JH; Ferrari G
Expert Rev Vaccines; 2006 Aug; 5(4):505-16. PubMed ID: 16989631
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte subsets and abnormalities in retrovirally infected mice.
Popp DM
Crit Rev Immunol; 1990; 10(2):73-112. PubMed ID: 1963783
[No Abstract] [Full Text] [Related]
6. [Polyclonal B cell activation in infection caused by human immunodeficiency virus (HIV)].
Exquis B; Perrin L; Link L; Scrignari V; Hirschel B; Zubler R; Miescher PA
Schweiz Med Wochenschr; 1987 Nov; 117(47):1863-5. PubMed ID: 3501163
[TBL] [Abstract][Full Text] [Related]
7. AIDS vaccines: back to 'plan A'.
Check E
Nature; 2003 Jun; 423(6943):912-4. PubMed ID: 12827164
[No Abstract] [Full Text] [Related]
8. A molecular clone of simian-human immunodeficiency virus (DeltavpuSHIV(KU-1bMC33)) with a truncated, non-membrane-bound vpu results in rapid CD4(+) T cell loss and neuro-AIDS in pig-tailed macaques.
McCormick-Davis C; Dalton SB; Hout DR; Singh DK; Berman NE; Yong C; Pinson DM; Foresman L; Stephens EB
Virology; 2000 Jun; 272(1):112-26. PubMed ID: 10873754
[TBL] [Abstract][Full Text] [Related]
9. Membrane tumour necrosis factor-alpha is involved in the polyclonal B-cell activation induced by HIV-infected human T cells.
Macchia D; Almerigogna F; Parronchi P; Ravina A; Maggi E; Romagnani S
Nature; 1993 Jun; 363(6428):464-6. PubMed ID: 7684824
[TBL] [Abstract][Full Text] [Related]
10. [The infection and immunity of HIV: hope and thought].
Shang H
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):220-2. PubMed ID: 17425861
[No Abstract] [Full Text] [Related]
11. The immunologic aspects of human immunodeficiency virus infection in the gastrointestinal tract.
Schneider T; Ullrich R; Zeitz M
Semin Gastrointest Dis; 1996 Jan; 7(1):19-29. PubMed ID: 8903576
[TBL] [Abstract][Full Text] [Related]
12. Immunology and the elusive AIDS vaccine.
Virgin HW; Walker BD
Nature; 2010 Mar; 464(7286):224-31. PubMed ID: 20220841
[TBL] [Abstract][Full Text] [Related]
13. Lack of pseudotype formation between human immunodeficiency virus type 1 and Epstein-Barr virus in productively coinfected B lymphoblastoid cell lines.
Van Kuyk R; Mosier DE
Virology; 1995 Jun; 209(2):643-8. PubMed ID: 7778296
[TBL] [Abstract][Full Text] [Related]
14. Induction of HIV-specific T and B cell responses with a replicating and conditionally infectious lentiviral vaccine.
Wingard JB; Anderson B; Weissman D
Eur J Immunol; 2008 May; 38(5):1310-20. PubMed ID: 18412164
[TBL] [Abstract][Full Text] [Related]
15. Antigen presentation and related immunological aspects of HIV-1 vaccines.
Steinman RM; Germain RN
AIDS; 1998; 12 Suppl A():S97-112. PubMed ID: 9632991
[No Abstract] [Full Text] [Related]
16. Host immunity and the course of HIV infection.
Bentwich Z; Wainberg MA
Isr J Med Sci; 1993 Oct; 29(10 Suppl):34-6. PubMed ID: 8244678
[TBL] [Abstract][Full Text] [Related]
17. [HIV-1 infection: pathogenesis of immune suppression].
Stingl G
Wien Med Wochenschr; 1988 Oct; 138(19-20):487-92. PubMed ID: 2904717
[TBL] [Abstract][Full Text] [Related]
18. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
[TBL] [Abstract][Full Text] [Related]
19. Mucosal gatekeepers: selecting HIV viruses for early infection.
Bomsel M; David V
Nat Med; 2002 Feb; 8(2):114-6. PubMed ID: 11821891
[No Abstract] [Full Text] [Related]
20. Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques.
Hazuda DJ; Young SD; Guare JP; Anthony NJ; Gomez RP; Wai JS; Vacca JP; Handt L; Motzel SL; Klein HJ; Dornadula G; Danovich RM; Witmer MV; Wilson KA; Tussey L; Schleif WA; Gabryelski LS; Jin L; Miller MD; Casimiro DR; Emini EA; Shiver JW
Science; 2004 Jul; 305(5683):528-32. PubMed ID: 15247437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
